These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20860064)

  • 1. Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response.
    Souza RP; Meltzer HY; Lieberman JA; Le Foll B; Kennedy JL
    Hum Psychopharmacol; 2010 Nov; 25(7-8):582-5. PubMed ID: 20860064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.
    Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ
    Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.
    Lett TA; Tiwari AK; Meltzer HY; Lieberman JA; Potkin SG; Voineskos AN; Kennedy JL; Müller DJ
    Schizophr Res; 2011 Nov; 132(2-3):121-4. PubMed ID: 21890328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia.
    Souza RP; de Luca V; Meltzer HY; Lieberman JA; Kennedy JL
    Pharmacogenet Genomics; 2010 Apr; 20(4):274-6. PubMed ID: 20168265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.
    Souza RP; Romano-Silva MA; Lieberman JA; Meltzer HY; MacNeil LT; Culotti JG; Kennedy JL; Wong AH
    J Psychiatr Res; 2010 Aug; 44(11):700-6. PubMed ID: 20116071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between clozapine response and allelic variation in the 5-HT2C receptor gene.
    Sodhi MS; Arranz MJ; Curtis D; Ball DM; Sham P; Roberts GW; Price J; Collier DA; Kerwin RW
    Neuroreport; 1995 Dec; 7(1):169-72. PubMed ID: 8742444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study between the neurexin-1 gene and tardive dyskinesia.
    Lanning R; Lett TA; Tiwari AK; Brandl EJ; de Luca V; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Remington G; Kennedy JL; Zai CC
    Hum Psychopharmacol; 2017 Jan; 32(1):. PubMed ID: 28120489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia.
    Ferrari M; Bolla E; Bortolaso P; Callegari C; Poloni N; Lecchini S; Vender S; Marino F; Cosentino M
    Psychiatry Res; 2012 Dec; 200(2-3):1014-7. PubMed ID: 22901441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms.
    Hishimoto A; Liu QR; Drgon T; Pletnikova O; Walther D; Zhu XG; Troncoso JC; Uhl GR
    Hum Mol Genet; 2007 Dec; 16(23):2880-91. PubMed ID: 17804423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control association study of NRXN1 polymorphisms with schizophrenia in Chinese Han population.
    Yue W; Yang Y; Zhang Y; Lu T; Hu X; Wang L; Ruan Y; Lv L; Zhang D
    Behav Brain Funct; 2011 Apr; 7():7. PubMed ID: 21477380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
    Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine.
    Zhao AL; Zhao JP; Zhang YH; Xue ZM; Chen JD; Chen XG
    Int J Neurosci; 2005 Nov; 115(11):1539-47. PubMed ID: 16223700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
    Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
    Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
    Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL
    Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of serotonin transporter gene polymorphisms on clozapine response in Brazilian schizophrenics.
    Kohlrausch FB; Salatino-Oliveira A; Gama CS; Lobato MI; Belmonte-de-Abreu P; Hutz MH
    J Psychiatr Res; 2010 Dec; 44(16):1158-62. PubMed ID: 20452607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete penetrance of NRXN1 deletions in families with schizophrenia.
    Todarello G; Feng N; Kolachana BS; Li C; Vakkalanka R; Bertolino A; Weinberger DR; Straub RE
    Schizophr Res; 2014 May; 155(1-3):1-7. PubMed ID: 24680031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenal system, neurotrophic factors and clozapine response: association with FKBP5 and NTRK2 genes.
    Mitjans M; Catalán R; Vázquez M; González-Rodríguez A; Penadés R; Pons A; Massana G; Munro J; Arranz MJ; Arias B
    Pharmacogenet Genomics; 2015 May; 25(5):274-7. PubMed ID: 25751398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
    Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL
    PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers.
    Jeong SH; Joo EJ; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):975-83. PubMed ID: 15380858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.